Event organizer will implement charitable giving through non-profit’s vaccine donation program.
Pharmaceutical Business Conference Group (PBCG), a clinical trials conference organizer, will partner with Greater Gift, a non-profit with the mission to increase awareness of clinical research as a care option, to implement charitable giving programs at its Clinical Outsourcing Group meetings, which are held globally throughout the year.
"We are thrilled to partner with Pharmaceutical Business Conference Group to further our mission and simplify the process for corporations and individuals to contribute to pay forward the gift of health," said Joan Chambers, CEO of Greater Gift, in a release. She added, "PBCG events attract top leaders in the pharmaceutical space, establishing their conferences as an ideal platform for increasing charitable contributions from this community."
The program will utilize Greater Gift’s collaboration with GAVI, the Vaccine Alliance. PBCG outsourcing speakers will use a referral code for pharmaceutical and biotech colleagues to register, triggering a PBCG donation. The charity, with GAVI, then donates a vaccine to a child in need. Registrants receive notification post-event as to how many donations their contributions made.
The new charitable referral program debuts at PBCG's Clinical Outsourcing Group Europe meeting on October 10 and 11 in Milan, Italy.
Reference: “Pharmaceutical Business Conference Group Partners with Greater Gift to Expand Vaccine Donation Programme,”London, United Kingdom, August 23, 2023.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.